Form 4: Amgen EVP Murdo Gordon Executes Stock Disposition

Amgen Inc. Executive Vice President Murdo Gordon reported the disposition of 1,593 shares of common stock to satisfy tax withholding obligations.

Summary

• Murdo Gordon, EVP of Global Commercial Operations at Amgen Inc., disposed of a total of 1,593 shares of common stock on May 2, 2026.
• The transaction consisted of two separate dispositions of 830 shares and 763 shares, both executed at a price of $329.82 per share.
• The shares were withheld by the company to satisfy tax obligations related to the vesting of equity awards.
• Following these transactions, the reporting person maintains a direct beneficial ownership of 48,699 shares of Amgen common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the transaction is purely administrative and related to tax obligations rather than a strategic shift or market-driven sale.

Positives

• The transaction was a routine administrative action related to tax withholding upon the vesting of equity awards, rather than a discretionary open-market sale.

Negatives

• Reduction in the reporting person's direct equity stake in the company.

Risks

• None identified; this is a standard regulatory disclosure of a non-discretionary tax-related transaction.

Future Outlook

Not applicable; this filing pertains to a historical transaction and does not provide forward-looking guidance.

Industry Context

StockSavvy.ai notes that routine tax-related share dispositions by high-level executives are standard industry practice and generally do not signal a change in management sentiment regarding company performance.

Comparison to Industry Standards

• The transaction aligns with standard corporate governance practices for executive compensation and tax compliance within the large-cap biotechnology sector.

Stakeholder Impact

• Minimal impact on shareholders as the transaction was non-discretionary and related to tax withholding.

Key Dates

Keywords

Amgen, AMGN, Insider Trading, Form 4, Equity Compensation, Tax Withholding